Francesco Ferraù

Gender differences in the glycometabolic and cardiovascular features of acromegaly.

AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy

Reply to: Rethinking the global epidemiology of pheochromocytoma: glimpses of a larger reality

A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas

The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell’Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO)

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients

Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy

Global Cushing’s disease epidemiology: a systematic review and meta-analysis of observational studies

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score

Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study

Long-term cardiometabolic outcome in patients with pituitary adenoma diagnosed in chilhood and adolescence

Quality of Life in Women Diagnosed with Breast Cancer after a 12-Month Treatment of Lifestyle Modifications

Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial

What we have to know about corticosteroids use during Sars-Cov-2 infection

Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma

What we have to know about corticosteroids use during Sars-Cov-2 infection

MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior

High bone marrow fat in patients with Cushing's syndrome and vertebral fractures.

Gastroenteropancreatic neuroendocrine neoplasms and inflammation: A complex cross-talk with relevant clinical implications.

Avelumab as single agent for patients with metastatic or locally advanced urothelial cancer PD-L1+ unfit for cisplatin: The ARIES study.

Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients

Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study

Association of body mass index and systemic inflammation index with survival in patients with renal cell cancer treated with nivolumab.

Paradoxical GH Increase During OGTT Is Associated With First-Generation Somatostatin Analog Responsiveness in Acromegaly

Phase III Study with FOLFIRI + Cetuximab Versus FOLFIRI + Cetuximab Followed by Cetuximab Alone in <i>RAS</i> and <i>BRAF</i> WT mCRC

Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study